These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Metformin-associated hepatotoxicity]. Olivera-González S; de Escalante-Yangüela B; Velilla-Soriano C; Amores-Arriaga B; Martín-Fortea P; Navarro-Aguilar ME Med Intensiva; 2010 Oct; 34(7):483-7. PubMed ID: 20045581 [TBL] [Abstract][Full Text] [Related]
3. Probable hepatotoxicity associated with the use of metformin in type 2 diabetes. Hashmi T BMJ Case Rep; 2011 Sep; 2011():. PubMed ID: 22679227 [TBL] [Abstract][Full Text] [Related]
4. [Constitutional syndrome associated to metformin induced hepatotoxicity]. de la Poza Gómez G; Rivero Fernández M; Vázquez Romero M; Angueira Lapeña T; Arranz de la Mata G; Boixeda de Miquel D Gastroenterol Hepatol; 2008 Dec; 31(10):643-5. PubMed ID: 19174081 [TBL] [Abstract][Full Text] [Related]
6. Metformin as a Rare Cause of Drug-Induced Liver Injury, a Case Report and Literature Review. Zheng L Am J Ther; 2016; 23(1):e315-7. PubMed ID: 24263160 [TBL] [Abstract][Full Text] [Related]
9. Hepatotoxicity associated with metformin therapy in treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease. Cone CJ; Bachyrycz AM; Murata GH Ann Pharmacother; 2010 Oct; 44(10):1655-9. PubMed ID: 20647417 [TBL] [Abstract][Full Text] [Related]
10. Possible metformin-induced hepatotoxicity. Kutoh E Am J Geriatr Pharmacother; 2005 Dec; 3(4):270-3. PubMed ID: 16503324 [TBL] [Abstract][Full Text] [Related]
11. Case report. Pseudohepatotoxicity of metformin. Swislocki AL; Noth R Diabetes Care; 1998 Apr; 21(4):677-8. PubMed ID: 9571371 [No Abstract] [Full Text] [Related]
12. Clarifying metformin's role and risks in liver dysfunction. Brackett CC J Am Pharm Assoc (2003); 2010; 50(3):407-10. PubMed ID: 20452916 [TBL] [Abstract][Full Text] [Related]
14. Fatal hepatic necrosis following cardiac surgery and enflurane anaesthesia. Schneider M Anaesth Intensive Care; 1996 Apr; 24(2):289. PubMed ID: 9133216 [No Abstract] [Full Text] [Related]
15. [A new case: pioglitazone hepatotoxicity]. Martínez Odriozola P; Ibarmia Lahuerta J; Gutiérrez Macías A; de la Villa FM Med Clin (Barc); 2007 Jun; 129(4):158-9. PubMed ID: 17663974 [No Abstract] [Full Text] [Related]
16. Repaglinide induced acute hepototoxicity. Jaiswal S; Mehta R; Musuku M; Tran L; McNamee W JNMA J Nepal Med Assoc; 2009; 48(174):162-4. PubMed ID: 20387361 [TBL] [Abstract][Full Text] [Related]
17. Acute hepatotoxicity caused by repaglinide. Nan DN; Hernández JL; Fernández-Ayala M; Carrascosa M Ann Intern Med; 2004 Nov; 141(10):823. PubMed ID: 15545689 [No Abstract] [Full Text] [Related]
18. Summary for patients. Liver damage in a person taking the diabetes drug pioglitazone. Ann Intern Med; 2002 Mar; 136(6):I65. PubMed ID: 11900516 [No Abstract] [Full Text] [Related]
19. Acarbose-induced acute severe hepatotoxicity. Carrascosa M; Pascual F; Aresti S Lancet; 1997 Mar; 349(9053):698-9. PubMed ID: 9078205 [No Abstract] [Full Text] [Related]
20. Fatal hepatotoxicity associated with troglitazone. Vella A; de Groen PC; Dinneen SF Ann Intern Med; 1998 Dec; 129(12):1080. PubMed ID: 9867776 [No Abstract] [Full Text] [Related] [Next] [New Search]